Prevalence of Multidrug Resistant Tuberculosis and Its Associated Factors among Smear Positive TB Patients at Debre Markos Referral Hospital, Northwest Ethiopia
Keywords:
MDR-TB, prevalence, HIV, tuberculosis
Abstract
Background: The emergence of MDR-TB is a threat for the populations of resource limited countries. In Ethiopia multidrug resistant tuberculosis is becoming a challenge, because of poor adherence to treatment, TB/HIV co-infection, and a few diagnostic and treatment facilities. Objective: The main aim of this study was to assess prevalence and associated factor for multidrug resistant tuberculosis among smear positive TB patients Methods: A retrospective cross-sectional study was conducted among TB patients treated at DOT’s clinic at Debre Markos Referral Hospital from September 1, 2015 to March 10, 2017. Data was entered and analyzed using SPSS version 20. Logistic regression was employed to assess associated factors with p-value
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
URL: https://medicalresearchjournal.org/index.php/GJMR/article/view/1411
References
World Health Organization (2014) Global Tuberculosis Report.
WHO (2015) Global tuberculosis control report. WHO report 2015, Geneva, Switzerland; 1-204. Available at:. 1-204. http://www.who.int/about/licensing/copyright-form/en/index.html./
(2011) Global tuberculosis control report 2011. http://www.who.int/about/licensing/copyright_form/en/index
WHO (2013) Shorter treatment regimens for multidrugresistant tuberculosis, treatment outcomes observed in Bangladesh for Multidrug resistant-TB cases treated with a nine months regimen. 1-2. http://www.who.int/tb/challenges/mdr
WHO (2010) Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region. 1-81.
K. Kapadia, B. Tripathi (2013) Analysis of 63 patients of MDR TB on DOTS plus regimen. 68, 1-6.
Hirpa S, Medhin G, Girma B, Melese M, Mekonen A, Suarez P (2013) Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study. 13(1), 782. https://doi.org/10.1186/1471-2458-13-782
WHO (2012) Multidrug Resistant Tuberculosis, a critical global concern. 2012, 1-2. http://www.who.int/tb/publications/MDRFactSheet2012.pdf
(2013) Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. https://doi.org/10.1163/1570-6664_iyb_sim_org_38979
CSA (2007) The 2007 Population and Housing Census of Ethiopia: Statistical Report for Country level.
Adane K, Ameni G, Bekele S, Abebe M, Aseffa A (2015) Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, Northwest Ethiopia. 15, 572. https://doi.org/10.1186/s12889-015-1933-9
S. Gashaw (2014) Prevalence of MDR TB and treatment outcome among TB patients in St. Peter TB specialized hospital. http://etd.aau.edu.et/handle/123456789/5660
LiuQ, Zhu L, Shao Y, Song H, Li G, Zhou Y (2013) Rates and risk factors for drug resistance tuberculosis in Northeastern China. 13, 1171.
S. Sharma, G. Kaushik, B. Jha (2011) Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis. 133(3), 308-311.
Nagaraja C, Shashibhushan BL, Mohamed A, Manjunath PH, Sagar C (2012) Pattern of Drug-resistance and Treatment Outcome in Multidrug-resistant Pulmonary Tuberculosis. 54(1), 23-26. https://doi.org/10.5005/ijcdas-54-1-23
Maru M, Mariam SH, Airgecho T, Gadissa E, Aseffa A (2015) Prevalence of Tuberculosis, Drug Susceptibility Testing, and Genotyping of Mycobacterial Isolates from Pulmonary Tuberculosis Patients in Dessie, Ethiopia. 2015, 1-7.
Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D (2017) Rifampicinresistance patternof Mycobacterium tuberculosis and associatedfactors among presumptive tuberculosispatients referred to Debre Markos Referral Hospital, Ethiopia: a crosssectional study. 10, 8. https://doi.org/10.1186/s13104-016-2328-4
Seyoum B, Demissie M, Worku A, Bekele S, Assefa A (2014) Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia. 2014, 1-7. https://doi.org/10.1155/2014/753492
Biadglegne F, Sack U, Rodloff CA (2014) Multidrugresistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care. 3, 31.
Mekonen F, Tesema B, Moges F, Gelaw A, Eshetie S, Kmera G (2015) Multidrug resistance tuberclosis prevalence and risk factor in district hospital of Metema and Armacho, Northwest Ethiopia. 15, 461.
Mulu M, Mekonnen D, Yimer M, Admassu A, Abera B (2015) Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State Afr Health Sci. 15(2), 368. https://doi.org/10.4314/ahs.v15i2.9
A. Gemeda, A. Ketema, A. Alemseged, A. Ludwig, MulualemA, J. Bouke (2012) Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. (225).
Mesfin MY, Hailemariam D, Biadglign S, Kibret TK (2014) HIV/AIDS and Multi-Drug Resistance Tuberculosis: A Systematic Review and Meta- Analysis. 9(1), e82235. https://doi.org/10.1371/journal.pone.0082235
Akaninyene Otu, Victor Umoh, Abdulrazak Habib, Soter Ameh, Lovett Lawson, Victor Ansa (2013) Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria Pulmonary Medicine. 2013, 1-6. https://doi.org/10.1155/2013/235190
A. Somsak, W. Wanpen, K. Wanitchaya, N. Sriprapa, R. Somsak, S. Chawin (2010) Multi-drug resistant TB and HIV. 40, 1-15.
T. Fikadu (2015) Risk Factors for Multi-drug Resistant Tuberculosis. 3(2), 1-6.
Abebe G, Abdissa K, Abdissa A, Apers L, Agonafir M, De-jong B, Colebunders R (2012) Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. 5, 225. https://doi.org/10.1186/1756-0500-5-225
Haileyesus Getahun, Christian Gunneberg, Reuben Granich, Paul Nunn (2010) HIV Infection Associated Tuberculosis, the Epidemiology and the Response Clin Infect Dis. 50(s3), S201-S207. https://doi.org/10.1086/651492
M. Nirmalya, G. Kajaree, M. Malay (2014) Drug resistance pattern, related socio demographic factors and preventive practices among MDR-TB patients:An experience from a tertiary care setting: IOSR Journal of Dental and Medical Sciences 2014. 13(9), 16-21.
S. Manda, L. Masenyetse, J. Lancaster, M. van der Walt (2013) Risk of Death among HIV Co-Infected Multidrug Resistant Tuberculosis Patients, Compared to Mortality in the General Population of South Africa Journal of AIDS & Clinical Research. 3(7), 3-7.
CDC (2012) Management of contacts of MDR TB and XDR TB patients. 1-28.
Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R (2013) Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear- Positive Tuberculosis Patients in Uganda: Results of the First National Survey. 8(8), e70763. https://doi.org/10.1371/journal.pone.0070763
Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G (2015) Tuberculosis Treatment Non-Adherence and Lost to Follow Up among TB Patients with or without HIV in Developing Countries: A Systematic Review. 44(1), 1-11.
Y. Gelmanova, S. Keshavjee, GolubchikovaTV, V. Berezina, StrelisKA, YanovaVG (2007) Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. 85(09), 703-711. https://doi.org/10.2471/blt.06.038331
Published
2017-12-04
Issue
Section
License
Copyright (c) 2017 Authors and Global Journals Private Limited

This work is licensed under a Creative Commons Attribution 4.0 International License.